Skechers, known for its comfortable and affordable sneakers, agreed to a $9.4 billion deal to be taken private by 3G Capital.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Roche agreed Monday to acquire anti-obesity drug developer Carmot Therapeutics for an appetizing $3.1 billion.
Apple will likely face a lot of competition if it decides to get on the road.
After 50 years of performing, world-renowned shock rock group Kiss just played its final show, but the members say the show will go on.
President Trump wants to bring film-making back to Hollywood by imposing 100% tariffs on movies produced outside of the US.
In a bid to scale up against larger rivals, health insurance players Cigna and Humana are reportedly in talks over a possible merger.
America’s largest auto manufacturer is trying to regain Wall Street’s favor with buybacks and spending cuts on less promising projects.
On Tuesday, Virgin Atlantic conducted the first transatlantic flight by a commercial airliner fully powered by sustainable aviation fuel.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
Consumer tech is getting up close and personal this holiday season.
A white-hot healthcare sector powered an much of the job growth in the past six months, according to a Wall Street Journal analysis.
Tesla has gone all-in on electric vehicles, but Toyota is getting to say “I told you so” with its focus on hybrids.
The delay of Grand Theft Auto VI’s release threw a multibillion dollar wrench in forecasted revenues for a gaming industry in need of a hit.
It was only last year that 737 felt like the number of scandals Boeing was embroiled in, rather than the name of its narrow-body aircraft.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.